CoChat

Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity

Mommen, Geert P.M., Marino, Fabio, Meiring, Hugo D., Poelen, Martien C.M., van Gaans-van den Brink, Jacqueline A.M., Mohammed, Shabaz, Heck, Albert J.R., van Els, Cécile A.C.M. · 2016 · Molecular & Cellular Proteomics
Cited by 66

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/mcp.m115.055780

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 67

  1. Adamopoulou, 2013, Exploring the MHC-peptide matrix of central tolerance in the human thymus, Nat. Commun, 4, 2039, 10.1038/ncomms3039 · DOI · Paper page
  2. Suri, 2006, The wide diversity and complexity of peptides bound to class II MHC molecules, Curr. Opin. Immunol, 18, 70, 10.1016/j.coi.2005.11.002 · DOI
  3. Ovsyannikova, 2007, Mass spectrometry and peptide-based vaccine development, Clin. Pharmacol. Ther, 82, 644, 10.1038/sj.clpt.6100389 · DOI
  4. Thibodeau, 2012, Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy, Oncoimmunology, 1, 908, 10.4161/onci.21205 · DOI · Paper page
  5. Purcell, 2004, Isolation and characterization of naturally processed MHC-bound peptides from the surface of antigen-presenting cells, Methods Mol. Biol, 251, 291
  6. Lippolis, 2002, Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets, J. Immunol, 169, 5089, 10.4049/jimmunol.169.9.5089 · DOI · Paper page
  7. Dengjel, 2005, Autophagy promotes MHC class II presentation of peptides from intracellular source proteins, Proc. Natl. Acad. Sci. U.S.A, 102, 7922, 10.1073/pnas.0501190102 · DOI · Paper page
  8. Münz, 2012, Antigen processing for MHC class II presentation via autophagy, Front. Immunol, 3, 1, 10.3389/fimmu.2012.00009 · DOI
  9. Stenger, 2014, Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells, Clin. Vaccine Immunol, 21, 641, 10.1128/CVI.00665-13 · DOI
  10. Bergseng, 2014, Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires, Immunogenetics, 67, 73, 10.1007/s00251-014-0819-9 · DOI · Paper page
  11. Depontieu, 2009, Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy, Proc. Natl. Acad. Sci. U.S.A, 106, 12073, 10.1073/pnas.0903852106 · DOI · Paper page
  12. Benham, 2015, Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients, Sci. Transl. Med, 7, 290ra87, 10.1126/scitranslmed.aaa9301 · DOI · Paper page
  13. Fissolo, 2009, Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients, Mol. Cell. Proteomics, 8, 2090, 10.1074/mcp.M900001-MCP200 · DOI
  14. Hill, 2003, Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule, J. Immunol, 171, 538, 10.4049/jimmunol.171.2.538 · DOI · Paper page
  15. Chornoguz, 2012, Major Histocompatibility Complex Class II+ Invariant Chain Negative Breast Cancer Cells Present Unique Peptides That Activate Tumor-specific T Cells From Breast Cancer Patients, Mol. Cell. Proteomics, 1457, 10.1074/mcp.M112.019232 · DOI
  16. Dengjel, 2004, Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectrometry, Eur. J. Immunol, 34, 3644, 10.1002/eji.200425510 · DOI
  17. Collado, 2013, Composition of the HLA-DR-associated human thymus peptidome, Eur. J. Immunol, 43, 2273, 10.1002/eji.201243280 · DOI
  18. Granados, 2015, The nature of self for T cells—a systems-level perspective, Curr. Opin. Immunol, 34, 1, 10.1016/j.coi.2014.10.012 · DOI
  19. van Haren, 2011, HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII, Mol. Cell. Proteomics, 10, 10.1074/mcp.M110.002246 · DOI · Paper page
  20. Masterson, 2002, MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+precursors, Blood, 100, 701, 10.1182/blood.V100.2.701 · DOI · Paper page
  21. Hoefnagel, 2011, Response of MUTZ-3 dendritic cells to the different components of the Haemophilus influenzae type B conjugate vaccine: towards an in vitro assay for vaccine immunogenicity, Vaccine, 29, 5114, 10.1016/j.vaccine.2011.05.050 · DOI
  22. Hoonakker, 2015, In vitro innate immune cell based models to assess whole cell Bordetella pertussis vaccine quality: a proof of principle, Biologicals, 43, 100, 10.1016/j.biologicals.2014.12.002 · DOI
  23. Frese, 2012, Toward full peptide sequence coverage by dual fragmentation combining electron-transfer and higher-energy collision dissociation tandem mass spectrometry, Anal. Chem, 84, 9668, 10.1021/ac3025366 · DOI · Paper page
  24. Meiring, 2006, Stable isotope tagging of epitopes: a highly selective strategy for the identification of major histocompatibility complex class I-associated peptides induced upon viral infection, Mol. Cell. Proteomics, 5, 902, 10.1074/mcp.T500014-MCP200 · DOI
  25. Meiring, 2007, Targeted identification of infection-related HLA class I-presented epitopes by stable isotope tagging of epitopes (SITE), Curr. Protoc. Immunol, 10.1002/0471142735.im1603s77 · DOI
  26. Mommen, 2014, Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD), Proc. Natl. Acad. Sci. U.S.A, 111, 4507, 10.1073/pnas.1321458111 · DOI · Paper page
  27. Yu, 2014, CELLO2GO: a web server for protein subCELlular LOcalization prediction with functional gene ontology annotation, PLoS ONE, 9, e99368, 10.1371/journal.pone.0099368 · DOI · Paper page
  28. Karosiene, 2013, NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ, Immunogenetics, 65, 711, 10.1007/s00251-013-0720-y · DOI · Paper page
  29. Andreatta, 2013, Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach, Bioinformatics, 29, 8, 10.1093/bioinformatics/bts621 · DOI
  30. Colaert, 2009, Improved visualization of protein consensus sequences by iceLogo, Nat. Methods, 6, 786, 10.1038/nmeth1109-786 · DOI · Paper page
  31. Bassani-Sternberg, 2015, Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation, Mol. Cell. Proteomics, 14, 658, 10.1074/mcp.M114.042812 · DOI · Paper page
  32. Impens, 2010, A quantitative proteomics design for systematic identification of protease cleavage events, Mol. Cell. Proteomics, 9, 2327, 10.1074/mcp.M110.001271 · DOI
  33. Sun, 2013, Proteolytic characteristics of cathepsin D related to the recognition and cleavage of its target proteins, PLoS ONE, 8, e65733, 10.1371/journal.pone.0065733 · DOI
  34. Nelson, 1997, Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules, Proc. Natl. Acad. Sci. U.S.A, 94, 628, 10.1073/pnas.94.2.628 · DOI
  35. Larsen, 1996, T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides, J. Exp. Med, 184, 183, 10.1084/jem.184.1.183 · DOI · Paper page
  36. West, 2004, Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling, Science, 305, 1153, 10.1126/science.1099153 · DOI · Paper page
  37. Mi, 2013, Large-scale gene function analysis with the PANTHER classification system, Nat. Protoc, 8, 1551, 10.1038/nprot.2013.092 · DOI · Paper page
  38. Caron, 2015, An open-source computational and data resource to analyze digital maps of immunopeptidomes, Elife, 4, 1, 10.7554/eLife.07661 · DOI
  39. Seward, 2011, Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis, Mol. Cell. Proteomics, 10, 10.1074/mcp.M110.002477 · doi:10.1074/mcp.m110.002477
  40. Alvarez, 2008, The rheumatoid arthritis-associated allele HLA-DR10 (DRB1*1001) shares part of its repertoire with HLA-DR1 (DRB1*0101) and HLA-DR4 (DRB*0401), Arthritis Rheum, 58, 1630, 10.1002/art.23503 · doi:10.1002/art.23503
  41. Frese, 2013, Profiling of diet-induced neuropeptide changes in rat brain by quantitative mass spectrometry, Anal. Chem, 85, 4594, 10.1021/ac400232y · DOI
  42. Sasaki, 2013, Large-scale identification of endogenous secretory peptides using electron transfer dissociation mass spectrometry, Mol. Cell. Proteomics, 12, 700, 10.1074/mcp.M112.017400 · DOI
  43. Frese, 2011, Improved peptide identification by targeted fragmentation using CID, HCD and ETD on an LTQ-Orbitrap Velos, J. Proteome Res, 10, 2377, 10.1021/pr1011729 · DOI · Paper page
  44. Mommen, 2014, Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD), Proc. Natl. Acad. Sci. U.S.A, 111, 4507, 10.1073/pnas.1321458111 · DOI · Paper page
  45. Marino, 2015, Extended O-GlcNAc on HLA Class-I-Bound Peptides, J. Am. Chem. Soc, 10.1021/jacs.5b06586 · DOI · Paper page
  46. Weinzierl, 2006, Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface, Mol. Cell. Proteomics, 6, 102, 10.1074/mcp.M600310-MCP200 · DOI · Paper page
  47. Fortier, 2008, The MHC class I peptide repertoire is molded by the transcriptome, J. Exp. Med, 205, 595, 10.1084/jem.20071985 · DOI · Paper page
  48. Blanco, 2008, Dendritic cells and cytokines in human inflammatory and autoimmune diseases, Cytokine Growth Factor Rev, 19, 41, 10.1016/j.cytogfr.2007.10.004 · DOI · Paper page
  49. Watts, 2012, The endosome-lysosome pathway and information generation in the immune system, Biochim. Biophys. Acta, 1824, 14, 10.1016/j.bbapap.2011.07.006 · DOI · Paper page
  50. Chicz, 1993, Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles, J. Exp. Med, 178, 27, 10.1084/jem.178.1.27 · DOI · Paper page
  51. Rotzschke, 1994, Origin, structure and motifs of naturally processed MHC class II ligands, Curr. Opin. Immunol, 6, 45, 10.1016/0952-7915(94)90032-9 · DOI
  52. Juncker, 2009, Systematic characterisation of cellular localisation and expression profiles of proteins containing MHC ligands, PLoS ONE, 4, e7448, 10.1371/journal.pone.0007448 · DOI
  53. Schmid, 2006, Autophagy in innate and adaptive immunity against intracellular pathogens, J. Mol. Med, 84, 194, 10.1007/s00109-005-0014-4 · DOI
  54. Jaraquemada, 1990, An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells, J. Exp. Med, 172, 947, 10.1084/jem.172.3.947 · DOI · Paper page
  55. Jacobson, 1989, HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells, J. Virol, 63, 1756, 10.1128/jvi.63.4.1756-1762.1989 · DOI · Paper page
  56. Li, 2008, Efficient cross-presentation depends on autophagy in tumor cells, Cancer Res, 68, 6889, 10.1158/0008-5472.CAN-08-0161 · DOI · Paper page
  57. Li, 2011, Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy, Clin. Cancer Res, 17, 7047, 10.1158/1078-0432.CCR-11-0951 · DOI · Paper page
  58. Wang, 1999, Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen, Science, 284, 1351, 10.1126/science.284.5418.1351 · DOI · Paper page
  59. Dengjel, 2005, Autophagy promotes MHC class II presentation of peptides from intracellular source proteins, Proc. Natl. Acad. Sci. U.S.A, 102, 7922, 10.1073/pnas.0501190102 · DOI · Paper page
  60. Münz, 2009, Enhancing immunity through autophagy, Annu. Rev. Immunol, 27, 423, 10.1146/annurev.immunol.021908.132537 · DOI · Paper page
  61. Crotzer, 2009, Autophagy and its role in MHC-mediated antigen presentation, J. Immunol, 182, 3335, 10.4049/jimmunol.0803458 · DOI · Paper page
  62. Herberts, 2003, Dynamics of measles virus protein expression are reflected in the MHC class I epitope display, Mol. Immunol, 39, 567, 10.1016/S0161-5890(02)00204-3 · doi:10.1016/s0161-5890(02)00204-3
  63. Bozzacco, 2011, Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells, J. Proteome Res, 10, 5016, 10.1021/pr200503g · DOI · Paper page
  64. Yewdell, 2006, Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses, Immunity, 25, 533, 10.1016/j.immuni.2006.09.005 · DOI · Paper page
  65. Blum, 2013, Pathways of antigen processing, Annu Rev Immunol, 31, 443, 10.1146/annurev-immunol-032712-095910 · DOI · Paper page
  66. Villadangos, 2005, Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces, Immunol. Rev, 207, 191, 10.1111/j.0105-2896.2005.00317.x · DOI · Paper page
  67. Novellino, 2003, Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen, J. Immunol, 170, 6363, 10.4049/jimmunol.170.12.6363 · DOI

Cited by

See all 66

Metadata

Authors
Mommen, G. P. M., Marino, F., Meiring, H. D., Poelen, M. C. M., van Gaans-van den Brink, J. A. M., Mohammed, S., Heck, A. J. R., & van Els, C. A. C. M.
Venue
Molecular & Cellular Proteomics
Publisher
Elsevier BV
Published
2016-04
Volume
15
Issue
4
Pages
1412-1423
ISSN
1535-9476
Cited by
66
References
7
Language
en
Licence
Funders
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Project Proteins At Work (project 184.032.201), VIDI grant for Shabaz Mohammed (700.10.429))
  • Ministerie van Volksgezondheid, Welzijn en Sport (Strategic Research Project Immunoproteomics, Research Project Correlates of Protection)
  • Dutch Ministry of Education, Culture and Science (A Gravitation project at the Institute for Chemical Immunology)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity. https://app.cochat.ai/papers/10.1074/mcp.m115.055780
The paper
Mommen, G. P. M., Marino, F., Meiring, H. D., Poelen, M. C. M., van Gaans-van den Brink, J. A. M., Mohammed, S., Heck, A. J. R., & van Els, C. A. C. M. (2016). Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity. Molecular & Cellular Proteomics. https://doi.org/10.1074/mcp.m115.055780

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.